ArticleJournal of hepatocellular carcinoma2026
HAIC-Based versus TACE-Based Triple Therapy with Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Propensity Score-Matched Study.
Jun Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.